Arf Bio Yenilenebilir Enerji Uretim AS (IST:ARFYE) ROE %: 1.99% (As of Mar. 2026) — 76% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

IST:ARFYE Arf Bio Yenilenebilir Enerji Uretim AS IST:ARFYE
16 GF Score
Price ₺31.30
! 5 Warning Signs
View Full Analysis

What is Arf Bio Yenilenebilir Enerji Uretim AS ROE %?

Arf Bio Yenilenebilir Enerji Uretim AS IST:ARFYE -0.89% 16 ROE % is 1.99% as of Mar. 2026, which is 76% above its 10-year median of 1.13. GuruFocus rates IST:ARFYE with a GF Score™ of 16/100. The stock has 5 warning signs investors should review. Among 434 Utilities - Independent Power Producers companies, Arf Bio Yenilenebilir Enerji Uretim AS ranks worse than 64.06% on this metric.

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Arf Bio Yenilenebilir Enerji Uretim AS's annualized net income for the quarter that ended in Mar. 2026 was ₺33.2 Mil. Arf Bio Yenilenebilir Enerji Uretim AS's average Total Stockholders Equity over the quarter that ended in Mar. 2026 was ₺1,670.1 Mil. Therefore, Arf Bio Yenilenebilir Enerji Uretim AS's annualized ROE % for the quarter that ended in Mar. 2026 was 1.99%.

The historical rank and industry rank for Arf Bio Yenilenebilir Enerji Uretim AS's ROE % or its related term are showing as below:

IST:ARFYE' s ROE % Range Over the Past 10 Years
Min: 0.5   Med: 1.13   Max: 14.13
Current: 0.5

During the past 3 years, Arf Bio Yenilenebilir Enerji Uretim AS's highest ROE % was 14.13%. The lowest was 0.50%. And the median was 1.13%.

IST:ARFYE's ROE % is ranked worse than
64.06% of 434 companies
in the Utilities - Independent Power Producers industry
Industry Median: 3.82 vs IST:ARFYE: 0.50

Arf Bio Yenilenebilir Enerji Uretim AS  (IST:ARFYE) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=33.236/1670.051
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(33.236 / 844.32)*(844.32 / 2293.408)*(2293.408 / 1670.051)
=Net Margin %*Asset Turnover*Equity Multiplier
=3.94 %*0.3682*1.3733
=ROA %*Equity Multiplier
=1.45 %*1.3733
=1.99 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=33.236/1670.051
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (33.236 / 125.48) * (125.48 / 30.272) * (30.272 / 844.32) * (844.32 / 2293.408) * (2293.408 / 1670.051)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.2649 * 4.1451 * 3.59 % * 0.3682 * 1.3733
=1.99 %

Note: The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Arf Bio Yenilenebilir Enerji Uretim AS ROE % Related Terms


Arf Bio Yenilenebilir Enerji Uretim AS ROE % Historical Data

* Premium members only.

The historical data trend for Arf Bio Yenilenebilir Enerji Uretim AS's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Arf Bio Yenilenebilir Enerji Uretim AS ROE % Chart

Arf Bio Yenilenebilir Enerji Uretim AS Annual Data
Trend Dec22 Dec23 Dec24
ROE %
1.13 14.13 0.73

Arf Bio Yenilenebilir Enerji Uretim AS Quarterly Data
Dec22 Dec23 Dec24 Mar25 Sep25 Mar26
ROE % Get a 7-Day Free Trial 0.00 5.81 -22.20 0.00 1.99

Arf Bio Yenilenebilir Enerji Uretim AS ROE % Competitor Comparison

For the Utilities - Renewable subindustry, Arf Bio Yenilenebilir Enerji Uretim AS's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Arf Bio Yenilenebilir Enerji Uretim AS ROE % vs Utilities - Independent Power Producers Industry

For the Utilities - Independent Power Producers industry and Utilities sector, Arf Bio Yenilenebilir Enerji Uretim AS's ROE % distribution charts can be found below:

* The bar in red indicates where Arf Bio Yenilenebilir Enerji Uretim AS's ROE % falls into.


IST:ARFYE
16GF Score
Arf Bio Yenilenebilir Enerji Uretim AS IST:ARFYE
ROE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Arf Bio Yenilenebilir Enerji Uretim AS ROE % Calculation

Arf Bio Yenilenebilir Enerji Uretim AS's annualized ROE % for the fiscal year that ended in Dec. 2024 is calculated as

ROE %=Net Income (A: Dec. 2024 )/( (Total Stockholders Equity (A: Dec. 2023 )+Total Stockholders Equity (A: Dec. 2024 ))/ count )
=7.968/( (988.139+1207.585)/ 2 )
=7.968/1097.862
=0.73 %

Arf Bio Yenilenebilir Enerji Uretim AS's annualized ROE % for the quarter that ended in Mar. 2026 is calculated as

ROE %=Net Income (Q: Mar. 2026 )/( (Total Stockholders Equity (Q: Sep. 2025 )+Total Stockholders Equity (Q: Mar. 2026 ))/ count )
=33.236/( (1278.048+2062.054)/ 2 )
=33.236/1670.051
=1.99 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Mar. 2026) net income data. ROE % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROE % →
What does a ROE % of 1.99% mean?
Arf Bio Yenilenebilir Enerji Uretim AS (IST:ARFYE) has a ROE % of 1.99% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Arf Bio Yenilenebilir Enerji Uretim AS and its competitors. This is 76% above median its historical median of 1.13. Over the past decade, Arf Bio Yenilenebilir Enerji Uretim AS's ROE % has ranged from 0.50 to 14.13. According to the industry distribution chart, Arf Bio Yenilenebilir Enerji Uretim AS ranks #278 out of 434 companies in the Utilities - Independent Power Producers industry, placing it in the top 64.1%.
Is Arf Bio Yenilenebilir Enerji Uretim AS's ROE % too high?
Arf Bio Yenilenebilir Enerji Uretim AS's current ROE % of 1.99% is 76% above median its 10-year median of 1.13. Over the past 10 years, this metric has ranged from a low of 0.50 to a high of 14.13. The Utilities - Independent Power Producers industry median ROE % is 3.82. Arf Bio Yenilenebilir Enerji Uretim AS's value of 1.99% is 47.9% below this industry median. Based on the distribution chart, Arf Bio Yenilenebilir Enerji Uretim AS ranks #278 out of 434 companies in the Utilities - Independent Power Producers industry, which is below the industry midpoint. Overall, Arf Bio Yenilenebilir Enerji Uretim AS has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Arf Bio Yenilenebilir Enerji Uretim AS's ROE % compare to competitors?
According to the Utilities - Independent Power Producers industry distribution chart, Arf Bio Yenilenebilir Enerji Uretim AS ranks #278 out of 434 companies for ROE %. This places Arf Bio Yenilenebilir Enerji Uretim AS in the lower half of its industry. The industry median ROE % is 3.82. Arf Bio Yenilenebilir Enerji Uretim AS's value of 1.99% is 47.9% below this benchmark. Historically, Arf Bio Yenilenebilir Enerji Uretim AS's own ROE % has ranged from 0.50 to 14.13 over the past decade. While the company's 10-year median is 1.13 vs. the industry median of 3.82, Arf Bio Yenilenebilir Enerji Uretim AS has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for an Utilities - Independent Power Producers company?
The median ROE % among Utilities - Independent Power Producers companies is 3.82, based on 434 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Arf Bio Yenilenebilir Enerji Uretim AS's current ROE % of 1.99% is 47.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Arf Bio Yenilenebilir Enerji Uretim AS and its competitors. For the Utilities - Independent Power Producers industry, the median ROE % is 3.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Arf Bio Yenilenebilir Enerji Uretim AS's current ROE % is 1.99%, which is 76% above median its own 10-year median of 1.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arf Bio Yenilenebilir Enerji Uretim AS stock overvalued right now?
Arf Bio Yenilenebilir Enerji Uretim AS (IST:ARFYE) has a current ROE % of 1.99%. The current ROE % is 1.99%, which is 76% above median its 10-year median of 1.13 and 47.9% below the Utilities - Independent Power Producers industry median of 3.82. Arf Bio Yenilenebilir Enerji Uretim AS's overall GF Score™ is 16/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Arf Bio Yenilenebilir Enerji Uretim AS (IST:ARFYE), the current ROE % is 1.99% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Arf Bio Yenilenebilir Enerji Uretim AS Business Description

Address Nergiz Street, No: 9/36, Bestepe Neighborhood, Yenimahalle, Ankara, TUR
Arf Bio Yenilenebilir Enerji Uretim AS operates in the renewable energy sector. The company is engaged in biomass sector that focused on transforming waste that causes environmental pollution into efficient end products. its Biogas Technology enables the generation of energy from organic waste materials, increases soil fertility with organic-organomineral fertilizers, and generation of electricity.
16GF Score

Get the complete analysis for IST:ARFYE

ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₺31.30
Price